A survey of community-dwelling older adults.

No reduced risk for invasive cancer, either.

Novel agent is on fast-track for approval.

The guidance documents cover antibiotic prescribing for UTIs, acute pyelonephritis, and acute prostatitis

Both central and general obesity play a role.

Data underscore the importance of vaccination.

International guidelines are rarely followed in clinical practice.

Findings from the UK COMPARE study.

ACCEPt: a pragmatic, cluster-randomised controlled trial assessed women and men aged 16–29 years

1 agent fast-tracked for approval in US.

Combination therapies including desmopressin are more effective than monotherapies.

Cochrane review on daily phosphodiesterase type 5 inhibitors vs on-demand use, intraurethral prostaglandin E1 and no treatment.

First siderophore agent to reach late clinical development.

Secondary analysis of the Testosterone Trials shows consistent benefit in self-reported mobility.